Question · asked by 1 review

Intratympanic corticosteroids vs systemic corticosteroids: Proportion of patients whose hearing is improved

Population
sudden sensorineural hearing loss
Intervention
Intratympanic corticosteroids
Comparison
systemic corticosteroids
Outcome
Proportion of patients whose hearing is improved

Intratympanic corticosteroids showed no clear difference in proportion of patients whose hearing is improved compared with systemic corticosteroids (moderate certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Intratympanic corticosteroids vs systemic corticosteroids
Proportion of patients whose hearing is improved · sudden sensorineural hearing loss
Intratympanic corticosteroids showed no clear difference in proportion of patients whose hearing is improved compared with systemic corticosteroids (moderate certainty).
Intratympanic corticosteroids for sudden sensorineural hearing loss (2022) · Cochrane Headline outcomes only
RR 1.04 [0.97, 1.12]14 studies · 972 participantsModerate

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Intratympanic corticosteroids for sudden sensorineural hearing loss
2022 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.